Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program

NACompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

June 5, 2022

Study Completion Date

June 5, 2022

Conditions
Deep Vein ThrombosisAtrial FibrillationMitral Valve Disease
Interventions
OTHER

Anticoagulation Stewardship Program

"A clinical-pharmacist led anticoagulation stewardship program that includes:~1. Warfarin monitoring and dosing protocol. 1a.Warfarin initial dosing algorithm. 1b.Recommended International normalized ration (INR) target and duration of Warfarin therapy by indication.~1c.Warfarin dosage adjustment algorithms.~1d.Management of high INR values. 2-Heparin weight-based protocol. 3-Perioperative anticoagulation use protocol. 4-Policies that address baseline and ongoing laboratory monitoring for anticoagulants.~5-Protocol for Heparin Induced Thrombocytopenia(HIT) management. 6-Anticoagulation reversal protocol. 7-Booklet for anticoagulant drugs and all of previously prepared protocols. 8-Education programs regarding anticoagulation's therapy for health care team dealing with anticoagulation and patients."

Trial Locations (1)

11566

Faculty of Pharmacy, Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03812848 - Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program | Biotech Hunter | Biotech Hunter